BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21933134)

  • 1. Expression and characterization of a variant of TACI (CRD2-shortTACIFc) in Pichia pastoris.
    Wang R; Zhou S; Peng X; Zhou XW; Xie ZQ; Wang Y; Mo W; Yu M
    Protein Pept Lett; 2012 Mar; 19(3):315-25. PubMed ID: 21933134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding.
    Hymowitz SG; Patel DR; Wallweber HJ; Runyon S; Yan M; Yin J; Shriver SK; Gordon NC; Pan B; Skelton NJ; Kelley RF; Starovasnik MA
    J Biol Chem; 2005 Feb; 280(8):7218-27. PubMed ID: 15542592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
    Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
    Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
    Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
    Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.
    Nys J; Smulski CR; Tardivel A; Willen L; Kowalczyk C; Donzé O; Huard B; Hess H; Schneider P
    PLoS One; 2013; 8(4):e61350. PubMed ID: 23620746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.
    Schuepbach-Mallepell S; Das D; Willen L; Vigolo M; Tardivel A; Lebon L; Kowalczyk-Quintas C; Nys J; Smulski C; Zheng TS; Maskos K; Lammens A; Jiang X; Hess H; Tan SL; Schneider P
    J Biol Chem; 2015 Jun; 290(26):16330-42. PubMed ID: 25953898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
    Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
    Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Identification of Novel APRIL Peptide Antagonists and Binding Insights by Molecular Modeling and Immunosorbent Assays.
    Silva JH; Calmon-Hamaty F; Savino W; Hahne M; Caffarena ER
    Protein Pept Lett; 2015; 22(5):432-42. PubMed ID: 25731591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
    Tran NL; Schneider P; Santiago-Raber ML
    Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TACI regulates IgA production by APRIL in collaboration with HSPG.
    Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
    Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI.
    Marsters SA; Yan M; Pitti RM; Haas PE; Dixit VM; Ashkenazi A
    Curr Biol; 2000 Jun; 10(13):785-8. PubMed ID: 10898980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice.
    Uslu K; Coleman AS; Allman WR; Katsenelson N; Bram RJ; Alugupalli KR; Akkoyunlu M
    J Immunol; 2014 Apr; 192(8):3582-95. PubMed ID: 24646744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma.
    Lee L; Draper B; Chaplin N; Philip B; Chin M; Galas-Filipowicz D; Onuoha S; Thomas S; Baldan V; Bughda R; Maciocia P; Kokalaki E; Neves MP; Patel D; Rodriguez-Justo M; Francis J; Yong K; Pule M
    Blood; 2018 Feb; 131(7):746-758. PubMed ID: 29284597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
    González-Mendióroz M; Alvarez-Vázquez AB; Rubio-Martinez J
    J Mol Graph Model; 2013 Feb; 39():13-22. PubMed ID: 23202984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.
    Allman WR; Dey R; Liu L; Siddiqui S; Coleman AS; Bhattacharya P; Yano M; Uslu K; Takeda K; Nakhasi HL; Akkoyunlu M
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4094-103. PubMed ID: 26170307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
    Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
    J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
    Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
    J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.
    Vosters JL; Roescher N; Illei GG; Chiorini JA; Tak PP
    Oral Dis; 2012 May; 18(4):365-74. PubMed ID: 22212434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparison of BLyS-binding peptides from phage display library and computer-aided design on BLyS-TACI interaction.
    Zhao Y; Hao X; Feng J; Shen B; Wei J; Sun J
    Int Immunopharmacol; 2015 Feb; 24(2):219-223. PubMed ID: 25533501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.